Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HTR1A | P08908 | 4/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 4/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9610791 | 0.99 | PABPC1 (0.36) | PABPC1CTDSP1GAAALDH1A1HTR1A | |
| SCHEMBL9610786 | 0.91 | PABPC1 (0.42) | PABPC1CTDSP1GAAALDH1A1HTR1A | |
| SCHEMBL9610785 | 0.90 | PABPC1 (0.40) | PABPC1CTDSP1GAAALDH1A1HTR1A | |
| SCHEMBL9612224 | 0.85 | PABPC1 (0.33) | PABPC1CTDSP1GAAALDH1A1HTR1A | |
| SCHEMBL9610778 | 0.85 | CA2 (0.43) | ALDH1A1TMEM97SIGMAR1 | |
| SCHEMBL9612232 | 0.84 | PABPC1 (0.32) | PABPC1CTDSP1GAA | |
| SCHEMBL9610779 | 0.83 | PABPC1 (0.38) | PABPC1CTDSP1GAAALDH1A1HTR1A | |
| SCHEMBL25714334 | 0.79 | CTDSP1 (0.44) | PABPC1CTDSP1GAAALDH1A1HTR1A | |
| SCHEMBL16807907 | 0.79 | — | — | |
| SCHEMBL9610796 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420294-B2 | Salt and photoresist composition comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-16 | — | — | US | disclosed |
| US-20120135351-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135351-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | C1R, AFF1, C1S | PABPC1 3394/4885CTDSP1 2087/4885GAA 4867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.